{
    "organizations": [],
    "uuid": "a352807cfe0454fb4fd60bdb7f29714b84843c14",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-proqr-announces-q1-loss-per-share/brief-proqr-announces-q1-loss-per-share-eur-0-34-idUSASC0A0WF",
    "ord_in_thread": 0,
    "title": "BRIEF-ProQR Announces Q1 Loss Per Share Eur 0.34",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - ProQR Therapeutics NV:\n* Q1 LOSS PER SHARE EUR 0.34 * AT MARCH 31, 2018, PROQR HELD CASH AND CASH EQUIVALENTS OF €38.0 MILLION, COMPARED TO €48.1 MILLION AT DECEMBER 31, 2017 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T19:11:00.000+03:00",
    "crawled": "2018-05-10T17:34:32.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "proqr",
        "therapeutic",
        "nv",
        "q1",
        "loss",
        "per",
        "share",
        "eur",
        "march",
        "proqr",
        "held",
        "cash",
        "cash",
        "equivalent",
        "million",
        "compared",
        "million",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}